" class="no-js "lang="en-US"> CamDiab - Medtech Alert
Thursday, March 30, 2023
CamDiab | Pharmtech Focus


About CamDiab


CamAPS® FX: The advanced, adaptive, hybrid closed-loop app that automatically adjusts insulin delivery via an insulin pump based on sensor glucose readings. Suitable from 1 years of age, including pregnancy, for use in people living with type 1 diabetes.

Related Story

Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes

April 28 2022

Abbott (NYSE: ABT), CamDiab and Ypsomed today announced that they are partnering to develop and commercialize […]